Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)

South Korea · Delayed Price · Currency is KRW

5,600.00

+210.00 (3.90%)

At close: Jul 31, 2026

Daehan Nupharm Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	205,389	202,401	202,187	204,223	197,957	166,586
Revenue Growth	-0.19%	0.11%	-1.00%	3.16%	18.83%	11.58%
Gross Profit	89,761	91,054	95,477	92,236	88,554	81,593
Operating Income	10,617	11,725	18,665	18,859	27,949	26,383
Net Income	15,677	15,258	15,468	12,542	24,317	15,694
Earnings Per Share	1116.99	1087.09	1102.08	893.60	1732.58	1118.17
EPS Growth	22.21%	-1.36%	23.33%	-48.42%	54.95%	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	33,383	33,003	37,517	23,780	29,370	22,319
Total Debt	107,551	98,956	59,427	36,598	36,642	36,920
Net Cash (Debt)	-74,167	-65,953	-21,910	-12,818	-7,272	-14,601
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-5284.34	-4699.10	-1561.08	-913.25	-518.12	-1040.30

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	1,956	5,061	18,947	12,567	14,253	16,583
Capital Expenditures	-43,536	-50,236	-33,029	-9,737	-3,432	-10,625
Free Cash Flow	-41,580	-45,175	-14,083	2,830	10,822	5,958
Free Cash Flow Growth	-	-	-	-73.85%	81.63%	45.96%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	43.70%	44.99%	47.22%	45.16%	44.73%	48.98%
Operating Margin	5.17%	5.79%	9.23%	9.23%	14.12%	15.84%
Pretax Margin	7.38%	7.40%	9.09%	10.13%	17.44%	14.15%
Profit Margin	7.63%	7.54%	7.65%	6.14%	12.28%	9.42%
FCF Margin	-20.24%	-22.32%	-6.97%	1.39%	5.47%	3.58%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	5.01	6.04	6.23	10.13	4.93	9.75
P/FCF Ratio	-	-	-	44.89	11.08	25.68
PS Ratio	0.38	0.46	0.48	0.62	0.61	0.92